120 related articles for article (PubMed ID: 34402101)
1. Recommendations for immunocytochemistry in lung cancer typing: An update on a resource-efficient approach with large-scale comparative Bayesian analysis.
Elmas H; Diel R; Önal B; Sauter G; Stellmacher F; Welker L
Cytopathology; 2022 Jan; 33(1):65-76. PubMed ID: 34402101
[TBL] [Abstract][Full Text] [Related]
2. Subclassification of non-small cell lung cancer by cytologic sampling: a logical approach with selective use of immunocytochemistry.
Kimbrell HZ; Gustafson KS; Huang M; Ehya H
Acta Cytol; 2012; 56(4):419-24. PubMed ID: 22846197
[TBL] [Abstract][Full Text] [Related]
3. Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Ota T; Kirita K; Matsuzawa R; Udagawa H; Matsumoto S; Yoh K; Niho S; Ishii G; Goto K
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2495-2506. PubMed ID: 31494736
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation.
Righi L; Graziano P; Fornari A; Rossi G; Barbareschi M; Cavazza A; Pelosi G; Scagliotti GV; Papotti M
Cancer; 2011 Aug; 117(15):3416-23. PubMed ID: 21246522
[TBL] [Abstract][Full Text] [Related]
5. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.
Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A
Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709
[TBL] [Abstract][Full Text] [Related]
6. Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome.
Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M
J Thorac Oncol; 2014 Oct; 9(10):1540-6. PubMed ID: 25521399
[TBL] [Abstract][Full Text] [Related]
7. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA
Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-ligand 1 immunoexpression in matched biopsy and liquid-based cytology samples of advanced stage non-small cell lung carcinomas.
Jain D; Sukumar S; Mohan A; Iyer VK
Cytopathology; 2018 Dec; 29(6):550-557. PubMed ID: 29938855
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of cytology in sub typing non small cell lung carcinomas.
Patel TS; Shah MG; Gandhi JS; Patel P
Diagn Cytopathol; 2017 Jul; 45(7):598-603. PubMed ID: 28429425
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
[TBL] [Abstract][Full Text] [Related]
11. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
[TBL] [Abstract][Full Text] [Related]
12. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
[TBL] [Abstract][Full Text] [Related]
13. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
van Zyl A; Schubert PT; Koegelenberg CFN
Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
[TBL] [Abstract][Full Text] [Related]
15. Cytology-based treatment decision in primary lung cancer: is it accurate enough?
Sakr L; Roll P; Payan MJ; Liprandi A; Dutau H; Astoul P; Robaglia-Schlupp A; Loundou A; Barlesi F
Lung Cancer; 2012 Mar; 75(3):293-9. PubMed ID: 21975144
[TBL] [Abstract][Full Text] [Related]
16. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
17. Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Hammer SH; Prall F
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):550-7. PubMed ID: 25789531
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.
Johansson L
Ann Diagn Pathol; 2004 Oct; 8(5):259-67. PubMed ID: 15494931
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
J Thorac Oncol; 2011 Mar; 6(3):489-93. PubMed ID: 21258246
[TBL] [Abstract][Full Text] [Related]
20. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]